BG104240A - Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol - Google Patents

Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Info

Publication number
BG104240A
BG104240A BG104240A BG10424000A BG104240A BG 104240 A BG104240 A BG 104240A BG 104240 A BG104240 A BG 104240A BG 10424000 A BG10424000 A BG 10424000A BG 104240 A BG104240 A BG 104240A
Authority
BG
Bulgaria
Prior art keywords
salmeterol
compositions
methods
optically pure
treating pulmonary
Prior art date
Application number
BG104240A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas P. Jerussi
Original Assignee
Sepracor Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc. filed Critical Sepracor Inc.
Publication of BG104240A publication Critical patent/BG104240A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG104240A 1997-09-16 2000-03-14 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol BG104240A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/931,636 US6254882B1 (en) 1997-09-16 1997-09-16 Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
PCT/US1998/018845 WO1999013867A1 (fr) 1997-09-16 1998-09-10 Compositions de traitement de troubles pulmonaires a base de (s)-salmeterol optiquement pur et methodes correspondantes

Publications (1)

Publication Number Publication Date
BG104240A true BG104240A (en) 2001-04-30

Family

ID=25461118

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104240A BG104240A (en) 1997-09-16 2000-03-14 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol

Country Status (19)

Country Link
US (1) US6254882B1 (fr)
EP (1) EP1007008B1 (fr)
JP (1) JP2001516715A (fr)
KR (1) KR20010030610A (fr)
CN (1) CN1270515A (fr)
AT (1) ATE268166T1 (fr)
AU (1) AU754275B2 (fr)
BG (1) BG104240A (fr)
BR (1) BR9812643A (fr)
CA (1) CA2304265A1 (fr)
CZ (1) CZ290394B6 (fr)
DE (1) DE69824296T2 (fr)
ES (1) ES2221991T3 (fr)
HU (1) HUP0003488A3 (fr)
IL (1) IL135022A0 (fr)
NO (1) NO20001343D0 (fr)
NZ (1) NZ503563A (fr)
SK (1) SK3722000A3 (fr)
WO (1) WO1999013867A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
EP1212089B1 (fr) * 1999-08-21 2006-03-22 ALTANA Pharma AG Combinaison synergetique de roflumilast et salmeterol
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
WO2003024396A2 (fr) 2001-09-17 2003-03-27 Glaxo Group Limited Formulations de medicament en poudre seche
DE60302454T2 (de) * 2002-04-19 2006-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
AU2004240629B2 (en) * 2003-05-16 2010-02-25 Arriva Pharmaceuticals, Inc. Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
JPWO2004112791A1 (ja) * 2003-06-23 2006-07-27 協和醗酵工業株式会社 肺疾患の治療および/または予防剤
US8426475B2 (en) 2005-04-13 2013-04-23 Astion Development A/S Treatment of connective tissue diseases of the skin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
NZ235605A (en) 1989-10-10 1992-12-23 Glaxo Group Ltd (r)-(-)-4-hydroxy-alpha 1 -(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol and pharmaceutical compositions
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
GB9026005D0 (en) 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
CA2286913C (fr) * 1997-04-30 2008-12-09 Bridge Pharma, Inc. Composition et procedes employant un eutomere

Also Published As

Publication number Publication date
NO20001343L (no) 2000-03-15
HUP0003488A3 (en) 2003-05-28
IL135022A0 (en) 2001-05-20
CZ2000916A3 (cs) 2000-08-16
EP1007008A1 (fr) 2000-06-14
CN1270515A (zh) 2000-10-18
HUP0003488A2 (hu) 2001-02-28
ES2221991T3 (es) 2005-01-16
EP1007008A4 (fr) 2002-06-12
ATE268166T1 (de) 2004-06-15
SK3722000A3 (en) 2000-07-11
US6254882B1 (en) 2001-07-03
JP2001516715A (ja) 2001-10-02
NZ503563A (en) 2002-07-26
NO20001343D0 (no) 2000-03-15
DE69824296T2 (de) 2005-06-30
WO1999013867A1 (fr) 1999-03-25
CZ290394B6 (cs) 2002-07-17
DE69824296D1 (de) 2004-07-08
CA2304265A1 (fr) 1999-03-25
AU9228398A (en) 1999-04-05
EP1007008B1 (fr) 2004-06-02
KR20010030610A (ko) 2001-04-16
BR9812643A (pt) 2000-08-22
AU754275B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
AU681198B2 (en) Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates
BG104240A (en) Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
CA2245768A1 (fr) Procedes pour le traitement du vomissement et les troubles du systeme nerveux central au moyen de norcisapride (+) optiquement pur
DE59501599D1 (de) Verfahren zur Herstellung von Propandiol-1,2
ITVI930163A0 (it) Metodo per la realizzazione di supporti elestici integralli, nonche'supporti con esso ottenuti
IL122012A0 (en) Process for the separation of a mixture of enantiomers
AU7174191A (en) Optically pure r(-) albuterol for treating asthma
AU1315795A (en) Process for the preparation of an optically pure enantiomer of formoterol
DK0787715T3 (da) Fremgangsmåde til racematspaltning af tramadol
IT9019331A1 (it) Procedimento per la preparazione di levo e destro fenfluramina
ATE238271T1 (de) Desformoterol und verfahren zu seiner herstellung
PT938584E (pt) Processo para o fabrico do ácido (s)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico ou (r)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico
EP0968997A3 (fr) Procédé pour la préparation de la S-Aryl-L-cystéine et dérivés
FR2719998B1 (fr) Composition immunisante anti-hélicobacter pylori à base de catalase.
BR9103481A (pt) Composto,estereoisomero,composicao farmaceutica e processo para preparar um composto
ATE339423T1 (de) Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält
DE69802329D1 (de) Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen
WO2000010544A3 (fr) Procede prevenant l'apparition de l'asthme
EP1236715A3 (fr) Procédé pour la préparation de la S-aryl cystéine
AU755526C (en) 1-(4-arylpiperazin-1-YL)-3-(2-oxopyrrolidin/piperidin-1-YL) propanes used as potential therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders, a process for preparing such compounds and a method of treating above diseases using the compounds
AU7236494A (en) New method for n-cyclopropylation of aromatic amines, as well as compounds and compositions obtained
UA28664A (uk) Спосіб приготування горілки "карат"